S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
66,000% upside on tiny biotech? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
NYSE:SNN

Smith & Nephew (SNN) Stock Forecast, Price & News

$25.36
-0.06 (-0.24%)
(As of 09/22/2023 ET)
Compare
Today's Range
$25.33
▼
$25.54
50-Day Range
$25.36
▼
$31.29
52-Week Range
$21.77
▼
$33.08
Volume
1.18 million shs
Average Volume
741,864 shs
Market Capitalization
$11.07 billion
P/E Ratio
N/A
Dividend Yield
3.55%
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Smith & Nephew MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.15mentions of Smith & Nephew in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.20%
From $1.74 to $1.90 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

Medical Sector

677th out of 965 stocks

Surgical Appliances & Supplies Industry

16th out of 19 stocks

See Top Rated MarketRank™ Stocks Here

SNN stock logo

About Smith & Nephew (NYSE:SNN) Stock

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SNN Price History

SNN Stock News Headlines

September 22, 2023 | americanbankingnews.com
Smith & Nephew (NYSE:SNN) Rating Increased to Strong-Buy at StockNews.com
August 4, 2023 | seekingalpha.com
Smith & Nephew plc 2023 Q2 - Results - Earnings Call Presentation
September 24, 2023 | Legacy Research (Ad)
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
August 3, 2023 | msn.com
Smith & Nephew ups growth expectations after strong first half of 2023
August 3, 2023 | seekingalpha.com
Smith & Nephew Non-GAAP EPS of $0.35, revenue of $2.73B
August 3, 2023 | benzinga.com
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength
June 17, 2023 | finance.yahoo.com
Boeing, CyberArk Lead 5 Stocks Near Buy Points
June 12, 2023 | msn.com
Smith+Nephew gets FDA clearance for AETOS shoulder implant system
September 24, 2023 | Legacy Research (Ad)
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
June 12, 2023 | finance.yahoo.com
Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement
May 4, 2023 | marketwatch.com
Smith & Nephew falls Thursday, still outperforms market
April 27, 2023 | msn.com
Smith & Nephew reports strong first quarter growth with £44m sales uplift
April 14, 2023 | forbes.com
Smith & Nephew (SNN) Buy Write Still Good To Go
April 13, 2023 | forbes.com
Smith & Nephew Buy Write
March 31, 2023 | thestreet.com
Smith & Nephew Stock To Go Ex-dividend Tomorrow (SNN)
March 26, 2023 | finance.yahoo.com
Here's Why We're Wary Of Buying Smith & Nephew's (LON:SN.) For Its Upcoming Dividend
March 23, 2023 | finance.yahoo.com
New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
March 14, 2023 | marketwatch.com
Smith & Nephew rises Tuesday, outperforms market
March 13, 2023 | marketwatch.com
Smith & Nephew outperforms market despite losses on the day
March 9, 2023 | finance.yahoo.com
Smith & Nephew (SNN) Simplifies ACL Surgery With New Offers
March 8, 2023 | finance.yahoo.com
Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting
February 24, 2023 | seekingalpha.com
Smith & Nephew: Flat FY22 Growth, Now An Execution Story
February 24, 2023 | finance.yahoo.com
Investors’ Chronicle: Antofagasta, Hays, Smith & Nephew
February 23, 2023 | finance.yahoo.com
What Makes Smith & Nephew (SNN) a New Buy Stock
February 21, 2023 | msn.com
Smith & Nephew profits shrink amid major fall in Bioventus holding
February 17, 2023 | msn.com
Smith & Nephew reveals Rupert Soames will become next chairman
February 17, 2023 | msn.com
Medical devices maker Smith & Nephew reveals ex-Serco head Rupert Soames will become next chairman
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Company Calendar

Last Earnings
11/17/2014
Today
9/24/2023
Ex-Dividend for 11/1 Dividend
10/05/2023
Dividend Payable
11/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:SNN
CUSIP
N/A
CIK
845982
Web
www.smith-nephew.com
Phone
441923477100
Fax
44-20-7930-3353
Employees
19,012
Year Founded
1856

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
14.57
P/E Growth
1.29
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.50
Current Ratio
2.19
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$5.22 billion
Price / Sales
2.12
Cash Flow
$3.06 per share
Price / Cash Flow
8.30
Book Value
$12.08 per share
Price / Book
2.10

Miscellaneous

Outstanding Shares
436,700,000
Free Float
432,330,000
Market Cap
$11.07 billion
Optionable
Optionable
Beta
0.64

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Deepak S. Nath Ph.D. (Age 51)
    CEO & Director
    Comp: $5.96M
  • Ms. Anne-Francoise Nesmes (Age 51)
    CFO & Exec. Director
    Comp: $1.35M
  • Mr. Paul Connolly (Age 55)
    Pres of Global Operations
  • Mr. Andrew Swift
    VP of Investor Relations
  • Ms. Helen Barraclough (Age 43)
    Group Gen. Counsel & Company Sec.
  • Ms. Alison Parkes (Age 50)
    Chief Compliance Officer & Compliance APAC
  • Mr. Joe Metzger
    Sr. VP of Marketing Services & Communications
  • Mr. Philip G. Cowdy (Age 56)
    Chief Corp. Devel. & Corp. Affairs Officer
  • Ms. Elga Lohler (Age 55)
    Chief HR Officer
  • Mr. Bradley Cannon (Age 55)
    Pres of Global Orthopaedics

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













SNN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.
View SNN analyst ratings or view top-rated stocks.

How have SNN shares performed in 2023?

Smith & Nephew's stock was trading at $26.89 on January 1st, 2023. Since then, SNN stock has decreased by 5.7% and is now trading at $25.36.
View the best growth stocks for 2023 here.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,750,000 shares, an increase of 33.6% from the August 15th total of 1,310,000 shares. Based on an average daily volume of 809,700 shares, the days-to-cover ratio is presently 2.2 days. Currently, 0.4% of the company's shares are short sold.
View Smith & Nephew's Short Interest.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.59.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Thursday, August 3rd. Investors of record on Friday, October 6th will be given a dividend of $0.462 per share on Wednesday, November 1st. This represents a yield of 2.6%. The ex-dividend date is Thursday, October 5th.
Read our dividend analysis for SNN.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.90 per share and currently has a dividend yield of 3.56%.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by a number of retail and institutional investors. Top institutional investors include Scharf Investments LLC (0.49%), Goldman Sachs Group Inc. (0.28%), BlackRock Inc. (0.23%), Wells Fargo & Company MN (0.17%), JPMorgan Chase & Co. (0.14%) and Raymond James & Associates (0.14%).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $25.36.

How much money does Smith & Nephew make?

Smith & Nephew (NYSE:SNN) has a market capitalization of $11.07 billion and generates $5.22 billion in revenue each year.

How many employees does Smith & Nephew have?

The company employs 19,012 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353.

This page (NYSE:SNN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -